SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1342)6/12/2002 11:24:34 AM
From: seminole  Respond to of 1475
 
I am in for a trade.
The investment bankers will defend $2.5, so the risk is low.
We are do for a bounce in the bios.



To: scaram(o)uche who wrote (1342)6/28/2002 4:54:39 PM
From: scaram(o)uche  Respond to of 1475
 
Message 17670823

For example, he said, they have observed efficacy using this approach in models of rheumatoid arthritis

probably part of the justification for shoving vitaxin upfront for RA.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News